Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells
- PMID: 15870015
- DOI: 10.1016/j.clim.2005.02.018
Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells
Abstract
The importance of CD4+ CD25+ regulatory T cells (Treg) in maintaining immune homeostasis has been directly demonstrated in vivo by their manipulation in a number of autoimmune disease models in the mouse. In the study of human regulatory cells, we have found that the cells that consistently demonstrate the in vitro regulatory activity most similar to that described for murine cells in vitro are best identified by restricting the isolation of CD25+ CD4 T cells to those cells expressing only the highest levels of CD25, representing approximately 2-3% of total CD4 T cells. Thus, it is the CD4+ CD25high subset that exhibits the in vitro characteristics that are identical to the CD4+ CD25+ regulatory cells initially characterized in mice. Furthermore, the cells expressing medium to low levels of CD25 not only do not exhibit suppressive activity directly ex vivo, but also actually contain a significant proportion of CD62L- CD4 T cells which are believed to be in vivo activated T cells. Due to the inherent difficulties in using CD25 as a marker for the purification of Treg cells, the finding that selection of the CD25high subset of CD4+ CD25+ T cells minimizes the co-isolation of contaminating activated CD4 T cells is important for future studies of these Treg cells in human disease. In order to perform these studies, we first had to establish a highly reproducible 'micro in vitro co-culture' assay system to enable the functional analysis of high-purity, but low-yield regulatory populations derived from FACS sorting. With this system in place, we are poised to dissect the potential heterogeneity of mechanisms employed by highly specific subpopulations of CD4+ CD25+ cells.
Comment in
-
Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells.Clin Immunol. 2005 Nov;117(2):192; discussion 193. doi: 10.1016/j.clim.2005.08.008. Clin Immunol. 2005. PMID: 16214081 No abstract available.
Similar articles
-
Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.J Neurosci Res. 2003 Oct 15;74(2):296-308. doi: 10.1002/jnr.10766. J Neurosci Res. 2003. PMID: 14515359
-
Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.Eur J Immunol. 2004 Nov;34(11):3016-27. doi: 10.1002/eji.200324725. Eur J Immunol. 2004. PMID: 15376196
-
In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.Int Immunopharmacol. 2006 Dec 20;6(13-14):1883-8. doi: 10.1016/j.intimp.2006.07.032. Epub 2006 Sep 1. Int Immunopharmacol. 2006. PMID: 17161341
-
Human CD4+CD25+ regulatory T cells.Semin Immunol. 2004 Apr;16(2):89-98. doi: 10.1016/j.smim.2003.12.005. Semin Immunol. 2004. PMID: 15036232 Review.
-
CD4(+)CD25high regulatory T cells in human pregnancy.J Reprod Immunol. 2005 Apr;65(2):111-20. doi: 10.1016/j.jri.2005.01.004. J Reprod Immunol. 2005. PMID: 15811516 Review.
Cited by
-
Renal T cell infiltration occurs despite attenuation of development of hypertension with hydralazine in Envigo's female Dahl rat maintained on a low-Na+ diet.Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F572-F583. doi: 10.1152/ajprenal.00512.2018. Epub 2019 Jun 26. Am J Physiol Renal Physiol. 2019. PMID: 31241996 Free PMC article.
-
Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells.Retrovirology. 2007 Aug 9;4:57. doi: 10.1186/1742-4690-4-57. Retrovirology. 2007. PMID: 17688698 Free PMC article.
-
A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis.Clin Exp Immunol. 2006 Apr;144(1):25-34. doi: 10.1111/j.1365-2249.2006.03027.x. Clin Exp Immunol. 2006. PMID: 16542361 Free PMC article.
-
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.Cancer Immunol Immunother. 2007 May;56(5):641-8. doi: 10.1007/s00262-006-0225-8. Epub 2006 Sep 8. Cancer Immunol Immunother. 2007. PMID: 16960692 Free PMC article. Clinical Trial.
-
Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?Hum Reprod Update. 2009 Sep-Oct;15(5):517-35. doi: 10.1093/humupd/dmp004. Epub 2009 Mar 11. Hum Reprod Update. 2009. PMID: 19279047 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials